This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: ANF BMY CERN FSLR MGM

Stocks in this article: ANF BMY CERN FSLR MGM SYK AEO AMT


Abercrombie & Fitch (ANF) downgraded at Baird from Outperform to Neutral, Robert Baird said. $32 price target. Company is seeing lower sales, especially in Europe.

Abercrombie & Fitch downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $28 price target. Company could continue to struggle for several quarters.

Advantest (ATE) downgraded to sell at TheStreet Ratings.

BCD Semiconductor Manufacturing (BCDS) downgraded to sell at TheStreet Ratings.

Bristol-Myers (BMY) downgraded at Leerink from Outperform to Market Perform, Leerink Swann said. Stock could be rangebound, following the failure of its Hepatitis-C treatment.

Cerner (CERN) downgraded at Leerink to Market Perform, Leerink Swann said. Bookings growth is starting to decelerate.

Embraer (ERJ) rated new Buy at UBS. $32 price target. Bizjets / defense / aftermarket to drive growth.

First Solar (FSLR) upgraded at Baird from Neutral to Outperform, Robert Baird said. $30 price target. Company has a solid balance sheet and pipeline execution remains strong.

First Solar upgraded at Cantor from Hold to Buy, Cantor Fitzgerald said. Company can replace its project pipeline and transition to a more sustainable business model.

First Solar upgraded at ThinkEquity from Sell to Hold, ThinkEquity said. $16 price target. Company boosted its guidance and appears to have prior issues under control.

HSN (HSNI) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.

MGM Resorts (MGM) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. $11 price target. Second half recovery may not materialize in Las Vegas.

Pharmacyclics (PCYC) downgraded at Needham from Buy to Hold, Needham said. Valuation call.

Ralcorp (RAH) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $75 price target. Company is cutting costs.

Stryker (SYK) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $61 price target. Expect a challenging environment for hospital capital spending.

Titanium Metals (TIE) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Valuation call, based on a $17 price target.

Wright Express (WXS) downgraded at Sterne Agee to Neutral, Sterne Agee said. $73 price target. Estimates also cut, given macro risks.


American Eagle (AEO) numbers increased at Sterne Agee through 2013, Sterne Agee said. Higher sales are driving margin expansion. Neutral rating and new $21 price target.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs